NARRATIVE/SYSTEMATIC REVIEWS/META-ANALYSIS

The Impact of Digital Health Technologies on Chronic Disease Management

Muhammad Asif, BS Candidate¹; Pramod K. Gaur, PhD²

¹BS Candidate, City College of New York, New York, USA; ²Adjunct Professor, Pace University and President, Gaur Associates, White Plains, New York, USA

Keywords: Cancer, chronic disease, chronic obstructive pulmonary disease, congestive heart failure, diabetes, digital health, healthcare technology, hypertension, obesity, opioid use disorder, remote patient monitoring

Abstract

Advances in digital health technologies have the potential to redesign chronic disease management and enable new directions for better patient outcomes and improved healthcare delivery. The focus here is on congestive heart failure, diabetes mellitus, and opioid use disorder, with an emphasis on the identification of barriers to equitable implementation and to propose research directions to enhance digital health efficacy and scalability. Investing in digital health solutions and innovation makes it possible for the healthcare industry to maintain quality of care, achieve better patient outcomes, and lower the burden of chronic diseases on a healthcare system. This paper explores common challenges and opportunities and proposes future research directions. Unlike earlier reports that focused on implementation barriers and provided an umbrella review of patient experiences, this article uniquely synthesizes evidence across conditions to establish best practices and cross-cutting barriers. In addition, it highlights the growing role of artificial intelligence in digital health—a topic often underexplored in prior works.

Plain Language Summary

Despite the benefits of telehealth, digital health disparities remain a significant challenge, particularly for marginalized groups of people. Barriers such as socioeconomic factors, limited digital literacy, and uneven access to broadband internet disproportionately impact low-income and rural communities. Rural communities, lower-income populations, and elderly patients often struggle to access and use digital health tools.

 

 

This article places into perspective digital health technologies in the management of chronic diseases, thereby linking existing evidence to the hypothesis that, in fact, these technologies can bridge the gaps that exist in healthcare delivery. The findings pinpoint areas where digital health can contribute to more personalized and equitable healthcare by synthesizing recent advancements and practical implementations.

Many publications proclaim the role that telehealth plays in improving medication adherence, reducing readmission rates, and generally enhancing patient engagement. However, even as there is a clear upside to telehealth implementation, it does not come without challenges. For example, the use of digital health technologies calls for great attention to data privacy, interoperability, and concern for the digital divide.

Here, the authors extend prior work in the field by providing a wider comparative framework across major chronic medical conditions (i.e., diabetes mellitus [DM], congestive heart failure [CHF], hypertension, chronic obstructive pulmonary disease [COPD], obesity, cancer, and opioid use disorder [OUD]), not through individual disease-specific interventions. Many previous reviews, such as those by Pong et al.¹ and Taylor et al.,² provided a broad overview of digital health experiences within specific diseases but without synthesis across conditions. This report comprehensively identifies key trends in telehealth, such as the role of telehealth in the reduction of hospitalizations, improving medication adherence, and expanding healthcare access, while also discussing systemic barriers to its implementation. Our findings build on existing research by identifying gaps in digital health equity, addressing implementation barriers, and exploring innovative strategies such as artificial intelligence (AI) and machine learning to enhance digital healthcare delivery.

We pose the following research questions. How do digital health technologies impact patient outcomes across multiple chronic conditions? What are the primary implementation barriers to digital health solutions in chronic disease management? How can digital health technologies be optimized for equitable access and long-term sustainability?

Methods

A critical evaluation of the peer-reviewed literature was conducted using the following databases: PubMed, Scopus, and Google Scholar from 2010 to 2024. A structured search strategy was implemented, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, to ensure a comprehensive and reproducible review process. Some search terms included “telehealth,” “digital health,” “chronic disease management,” “remote patient monitoring,” “healthcare outcomes,” and “artificial intelligence in digital health.”

The inclusion criteria covered peer-reviewed studies in both developed and developing healthcare settings that examined digital health interventions in chronic disease management and presented patient outcome data, cost-effectiveness analysis, or policy recommendations. Studies were selected based on their relevance, methodological rigor, and alignment with the review objectives. Additionally, a risk-of-bias assessment was conducted to evaluate the strength of the included studies, ensuring a transparent and critical appraisal of the existing literature.

Exclusion criteria covered studies lacking empirical data (e.g., opinion pieces, editorials, conceptual frameworks without data), research focusing exclusively on acute care rather than chronic disease management, and studies lacking a clearly defined digital health intervention.

To ensure methodological rigor, a risk-of-bias assessment was performed for each study included, using the Cochrane Risk of Bias Tool for Randomized Controlled Trials (RCTs) and the Newcastle-Ottawa Scale for observational studies. Studies were categorized based on their design and methodological robustness. These included RCTs that were assessed for selection bias, blinding, completeness of follow-up, and outcome reporting. Cohort studies were evaluated for sample size adequacy, confounder control, and completeness of follow-up. Observational research articles were examined for potential bias in data collection, exposure measurement, and result interpretation.

Results

Opioid Use Disorder

The opioid epidemic is a significant danger to public health. It involves the misuse of approved prescription painkillers, such as hydrocodone, fentanyl, oxycodone, and tramadol, leading to addiction, overdose, and death.³ While opioid misuse can cause other complications (e.g., retinopathy, nephropathy, and neuropathy), the majority of its complications serve as the foundation for other life-threatening events, including but not limited to cardiovascular and cerebrovascular arterial diseases.⁴

Opioid abuse strains the healthcare system, which can be overburdened by the involvement of law enforcement, with increased morbidity and mortality. This review revealed that telehealth interventions by patients with OUD, including virtual consultations and digital behavioral health programs, hold promise for improved adherence to medication-assisted treatment and reduced rates of relapse.^5,6 This epidemic hits the hardest across rural and economically depressed areas such as in West Virginia, Ohio, and New Hampshire, USA, where prescription rates are high, and the health infrastructure and the economic situation are poor.⁷

Comorbid patient populations at higher risk include those who lack financial stability, young adults, older adults, and Native American communities—an upshot of a common set of socioeconomic and health determinants.⁸ High rates of prescriptions, when associated with high rates of misuse, also contribute to infectious diseases such as HIV and hepatitis C through needle sharing, further escalating public health concerns. While technology with various devices and telehealth makes living with OUD more manageable, the opioid crisis requires just as much forward-thinking and innovative solutions to, at a minimum, contain its negative influence regarding the public health.⁹

Telehealth has been rolled out as a crucial weapon in the overall fight against opioid abuse through virtual consultations, remote monitoring mechanisms, e-prescribing, and online mutual aid groups. Among the greatest contributions of telehealth to patients ensnared in the opioid epidemic is the ability to enhance adherence to the initially prescribed medication plan.¹⁰

In a study reported by Laura and colleagues in 2024,¹¹ the adherence rate of 96.2% to the buprenorphine medication was reported, signifying that telehealth has the potential to ensure that patients consistently use their prescribed opioid medication. The possibility of reducing the frequency of developing opioid-related complications is high when the rates of medication compliance and adherence are high.

The other advantage was that the participants had close monitoring and timely intervention, further implying that patients with OUD benefit from contacts with their counselors and medical providers, thereby providing for constant monitoring of their condition and timely changes in their medication program.¹² The significance to these patients follows from the fact that the interventions are provided regularly as part of a proactively managed condition, following the real-time data.¹³ For example, in one study, participants completed an average of 27 activities, which involved at least one daily check-in and one cognitive behavioral therapy (CBT) module.¹

In addition, the participants sent an average of 14 chat messages per week to their counselors, and in this manner, they created room for timely interventions by ensuring 100% of the patients accessed their medications without any incidences of being denied.¹⁴ For patients ensnared in the opioid epidemic, such a system ensures their condition is managed proactively, thereby significantly limiting the risk of relapse, overdose, and related implications. The study also reported that patients treated through telehealth had significant decreases in indicators of anxiety and depression. In particular, anxiety scores decreased by an average of 5.2 points out of 21 points, and depression scores decreased an average of 6.1 points out of 27 points over the 12-week intervention.¹⁵

For opioid epidemic-related patients, mental health is significant, as an increase in stress and depression can exacerbate symptoms of substance use disorder, leading to a cycle of dependence and relapse. Telehealth access to mental health support through comprehensive opioid addiction treatment and motivational interviewing (MI) services might offer other tools for opioid epidemic-related patients to manage their OUD. Study participants engaged in CBT with MI via telehealth had improvements in self-efficacy and well-being. Improvements in self-efficacy averaged 12.7 points out of 100 points. All these advances in an individual patient living with OUD in terms of mental health could mean fewer cravings, better coping mechanisms, and greater probability for a better chance of successful recovery.¹⁵

Telehealth also increases access to care and its convenience. One study revealed that access to treatment through a smartphone app was convenient, as well as valid and applicable to OUDs because this category of people often have problems accessing treatment and services for economic or physical reasons and because of other problems that arise, including, at times, great distances that must be traveled for this purpose.¹⁶ Of the participants, 96.2% showed high adherence to the prescribed opioid treatment, which again justifies the feasibility and convenience of care provided remotely.¹⁵

For individuals facing challenges in accessing traditional clinic-based care due to factors such as long distances, economic barriers, or physical constraints, telehealth offers a viable solution. The ability to receive care from the comfort of one’s home through a smartphone app removes travel and associated costs, thus making healthcare more accessible and affordable for those who struggle with OUD.¹⁶

Beyond that, telehealth could facilitate continuous education and self-management, two building blocks essential for dealing with OUD. Participants received a fully digital intervention with educational information, interactive features, and tools for allowing management delivered via a smartphone app. Such far-reaching effects facilitated the learning process and helped participants engage actively in their recovery processes. Specifically, many participants remained highly engaged with the treatment, which is crucial for a digital intervention to be beneficial in engaging participants in active participation in the learning process.¹⁵

For people battling OUD, such learning materials enable them to gain knowledge about the disease, including how to facilitate the management of their cravings, medications, coping, and lifestyle adjustments. Telehealth options, by offering patients self-management tools, work to ensure better outcomes in the treatment of opioid addiction and other general aspects of health and well-being.¹⁵

Evidence from the reported trial data also shows that the availability of telehealth behavioral support for pharmacology is a highly beneficial aspect of treatment for people struggling with OUD. Integrated medical support combined with behavioral treatment allows the patient to attain the necessary skills, which enable them to manage their conditions, adhere to treatment processes, and implement desirable changes that can lead to recovery. The trial reported that participants were engaged and motivated with the help of motivational information, gamification, and facility access. In particular, the participants completed numerous app modules and activities. This outcome indicates that the participants engage and actively become involved in the recovery treatment processes.¹⁵

Engagement for those battling opioid addiction is important in helping them achieve the necessary adherence to medication-assisted treatment, coping strategies, maintaining sobriety, and accessing supportive networks. Telehealth, by offering comprehensive behavioral support through its platforms, will help physicians empower their patients and facilitate the long-term management of OUD.¹⁵

Telehealth appears to be a ray of hope for overcoming the challenges of receiving quality treatment for OUD. This was especially the case during the COVID-19 pandemic. A recent study by Dr Abid Haleem, Prof., Mechanical Engineering, Jamia Millia Islamia, New Delhi, India, conducted an assessment of the feasibility and acceptability of a novel digital therapeutic intervention for OUD in an adult, in combination with buprenorphine–behavioral therapy. Twenty-seven adults with OUD were treated with the intervention for 12 weeks. Several benefits of telehealth in the management of OUD were reported. First, a significantly high number of abstinence days from opioids were reported by participants from baseline to the end of the 12-week intervention, which successfully evinced the result of the effectiveness of remote treatment in the reduction of opioid use.¹⁷

An additional set of psychological indicators that revealed notable improvements included significant declines in anxiety and depression indices among the participants, while abstinence self-efficacy and overall well-being scores significantly increased post the digital therapeutic intervention. These findings imply that telehealth interventions serve to handle the physical part of addictions to opioid use and, on the other hand, serve to improve the mental well-being of the patients by gaining access to psychosocial treatment from a distance.¹⁷

The use of telehealth, especially in people diagnosed with OUD, offers many categorical benefits, as summarized by a study by the American Medical Association. According to the research, one of the most systemic benefits is the expansion of access to telehealth on a permanent basis for OUD treatments using audiovisual and audio-only prescriptions of methadone and buprenorphine. It supports improved equity in access to therapeutic services and reduces stigma attributed to individuals seeking treatment for OUD, as stated by the research. The flexibility of giving patients take-home doses of methadone is also considered permanent in the research, increasing convenience and reducing the reasons that patients omit treatment doses.¹⁶

Moreover, telehealth makes a patient with an addiction history of under 1 year eligible for treatment, hence providing timely intervention and care. This is important for preventing the escalation of the disorder. In addition, telehealth ensures that the consumption of medication is initiated even while waiting for subsequent services. This is to say that individuals receive the care required promptly. The reduction of stigmatizing language and the inclusion of updated definitions in the regulation are part of the deal, hence destigmatizing OUD treatment and promoting a more humane and patient-centered approach.¹⁶

Online mutual aid groups help reduce isolation and increase motivation for a person in recovery.¹⁶ In fact, a study published in JAMA Psychiatry revealed that telehealth delivery of CBT in combination with contingency management markedly reduced opioid drug use and improved treatment plan adherence by patients. “The psychological mechanisms of CBT are to help the patients identify and alter negative thought processes and behavior that impact their addiction, and contingency management gives tangible benefits for achieving treatment goals, such as staying drug free.”² Table 1 offers a tabular presentation of key findings from two OUD clinical studies.

Table 1. A compilation of reported outcomes from two studies of patients with OUD.^5,6

Digital health tools	Outcome and implications	Key gaps and limitations	Future directions
Naloxone distribution through digital platforms	Enhanced overdose prevention and patient engagement. Improved access to treatment.	Digital literacy challenges, regulatory concerns surrounding online medication distribution.	AI-powered predictive analytics for relapse prevention and expansion of virtual peer-support groups.
Telehealth-delivered behavioral therapies	Cost-effective solution for underserved populations. Increases scalability of interventions.	Limited longitudinal data on telehealth effectiveness in OUD management.
AI: artificial intelligence; OUD: opioid use disorder.

Diabetes Mellitus

DM can affect any group, but older people, those with obesity, and individuals of specific racial or ethnic backgrounds are at increased risk. The rate of type 2 diabetes in the United States is rising among young, obese individuals. This is alarming because it places Native Americans at a disproportionately increased risk compared with other populations.¹⁸

Effective control is a priority, as diabetes is associated with the risk of complications such as retinopathy, nephropathy, peripheral neuropathy, and increased risk for cardiovascular disease. All this makes it a significant public health burden, with associated complications accounting for direct medical costs and lost productivity.⁵ The use of closed-loop systems, which combine the use of continuous glucose monitors and insulin pumps, achieves better glycemic control and an improved sense of well-being among patients.⁶ Thus, technology has emerged as a key resource in addressing these challenges, as it overcomes access barriers for rural or underserved populations, while real-time data aid in informed decision-making for better disease management.⁵

The Indian Health Service-Joslin Vision Network Teleophthalmology Program

The goal of informed decision-making for better disease management is evident in initiatives, such as the Indian Health Service-Joslin Vision Network Teleophthalmology (IHS-JVN) Program. This program was created to combat the elevated risks of vision loss due to DM among American Indians and Alaska Natives—populations with the highest rates of DM in the United States (more than twice that of the general population), which places them at an increased risk for diabetic retinopathy, a potentially sight-destroying condition if left undiagnosed and untreated.¹⁹

The IHS-JVN program provides high-quality, cost-effective annual diabetic eye exams via telemedicine technology, as suggested by guidelines, thereby significantly improving access for these patients to critical eye care. During primary care appointments, teleophthalmology technology digitizes photos of the retina without the need for dilation. These digital images are transmitted to a reading center, where ophthalmologists analyze and identify abnormalities that require further evaluation or treatment. This approach ensures timely diagnosis, which is critical in preventing severe vision loss. The program has significantly increased the percentage of individuals receiving yearly eye exams—essential, given that only about half of the populations of American Indians and Alaska Natives with DM previously received these critical exams.¹⁹

Telehealth’s benefits in this context are numerous. First, it offers greater convenience, as eye exams can be integrated into existing primary care visits, eliminating the need for separate appointments with a specialist. Second, teleophthalmology addresses geographic barriers by increasing access to care by a specialist for people in remote areas, eliminating the need for long-distance travel to receive care. This is especially significant for rural American Indian and Alaska Native communities where health facilities are scarce.¹⁹

Digital images are transmitted to the specialist for immediate review, enabling timely diagnosis and treatment planning, vital for conditions like diabetic retinopathy, where early intervention can prevent blindness.¹⁹

Additionally, the IHS-JVN program is cost-effective, reducing diabetes-related vision care expenses by facilitating early detection and treatment before complications escalate into more intensive and costly interventions. The program has contributed to a substantial decrease in blindness due to DM among American Indian and Alaska Native patients, underscoring the transformative potential of telehealth in managing chronic conditions like DM.¹⁹

Special Diabetes Program for Indians

The Division of Diabetes at IHS has implemented telehealth programs in other ways to enhance the management of DM, such as through the SDPI. These programs enable patients to receive specialized care remotely, which is crucial for American Indian communities with the highest prevalence of DM in the United States. Telehealth ensures timely and consistent monitoring of chronic diseases like DM by linking patients to a multidisciplinary team that includes endocrinologists, dietitians, and diabetes educators. This holistic approach supports individualized care plans, nutrition guidance, and lifestyle changes essential for managing DM. Moreover, telehealth fosters continuity in education and training for healthcare professionals, keeping them informed about the latest diabetes care protocols and practices.¹⁹

Regarding data management, telehealth programs streamline data management, reporting through systems such as the SDPI Outcomes System, which tracks key measures and outcomes, enabling continuous improvement in the care of DM using data-driven approaches.¹⁹

Conclusively, telehealth improves patient engagement and adherence to treatment plans through convenient and frequent follow-up, reducing time off work and long commutes, thereby enhancing the management and outcomes of chronic diseases.¹⁹

The Promoting Realistic Individual Self-Management program, which evaluated the application of telehealth to provide diabetes care to patients in rural Montana, USA, examined the feasibility and effectiveness of telehealth for diabetes care for this population. This study compared telehealth and face-to-face visits in terms of adherence to recommended preventive guidelines, control of vascular risk factors, patient satisfaction, and disease self-management. The findings were promising: 1 year after intervention, both telehealth and face-to-face patients experienced increased adherence to recommended dilated eye exams, better control of vascular risk factors, and higher patient satisfaction rates with diabetes care.²⁰

Specifically, adherence to recommended dilated eye exams increased by 31% among telehealth patients and 43% among face-to-face patients. Control of two or more vascular risk factors improved by 37% in telehealth patients compared to 69% in face-to-face patients. Patient satisfaction with diabetes care improved by 191% among telehealth patients and 131% among face-to-face patients. Additionally, telehealth patients reported higher adherence to blood glucose monitoring (97% vs. 89%) and dietary adherence (244% vs. 159%) compared to face-to-face patients. While face-to-face patients initially showed a higher increase in receiving monofilament foot tests (35% vs. 17%), the difference diminished by the second year. These findings validate telehealth’s ability to enhance preventive care, vascular risk factor management, and patient satisfaction, particularly in underserved populations. Finally, telehealth patients reported greater adherence to blood glucose monitoring and dietary recommendations compared to their face-to-face counterparts. The researchers concluded that telehealth is a viable strategy for addressing healthcare access disparities and promoting equitable diabetes care in rural communities.²⁰

Telehealth in diabetes management offers numerous benefits, as demonstrated by a study on the Virtual Diabetes Specialty Clinic. This study involved 234 participants with either type 1 or type 2 DM who received training and education on continuous glucose monitoring (CGM) through a virtual clinic staffed by endocrinologists and behavioral health specialists. Over 26 weeks, participants achieved significantly better glycemic outcomes. For instance, average HbA1c levels among patients with type 1 diabetes dropped from 7.8% at baseline to 7.1% after 3 months and remained stable at 6 months. Similarly, HbA1c levels in patients with type 2 diabetes decreased from 8.1% to 7.1% over the same period. Time-in-range for blood glucose levels increased by 11% for type 1 patients and 18% for type 2 patients. The virtual clinic model achieved near-universal CGM adoption, with 96% of type 1 and 94% of type 2 participants using CGMs.²¹

Individualized training sessions enabled participants to interpret CGM data and implement self-management strategies, which contributed to improved glycemic control. The remote consultation structure allowed for timely interventions, reducing the risk of hypoglycemic events. Behavioral health support was another key component, with over 50% of patients with type 1 DM and 43% of participants with type 2 DM attending multiple mental health visits. This resulted in significant reductions in diabetes distress and hypoglycemia-related anxiety. This study also highlighted the integration of decision-support technology and patient-facing mobile apps, which further enhanced self-management capabilities. Participants expressed high satisfaction with their diabetes care, emphasizing the benefits of remote monitoring and support. The findings demonstrate telehealth’s potential to overcome geographic barriers, improve clinical outcomes, and enhance patient satisfaction in diabetes care.²¹

Congestive Heart Failure

CHF is a chronic condition leading to symptoms such as shortness of breath, fatigue, and fluid retention. In addition, CHF often results in severe complications, including arrhythmias, stroke, and kidney damage, contributing to increased morbidity and mortality rates. It poses a significant burden on healthcare systems, requiring frequent hospitalizations, costly interventions, and intensive medical management. At greatest risk are elderly individuals, particularly those with comorbidities such as hypertension and DM, as well as socioeconomically disadvantaged populations.²²

It is particularly prevalent in rural and economically depressed regions such as Appalachia (spanning 206,000 square miles in 12 states, from Southern New York to Northern Mississippi), the Deep South (the southernmost tier of states in the South United States), and parts of the Midwest (12 states in the north-central United States), where limited healthcare infrastructure and challenging socioeconomic conditions exacerbate the disease burden.²² Technological integration in CHF management, including advanced monitoring devices, telehealth services, and remote patient management systems, has shown promise in improving patient outcomes. These tools enable continuous monitoring, allowing for timely interventions and reducing the need for frequent hospital visits.²³

Clinical research results demonstrate that telehealth improves patient outcomes, enhances quality of life, and reduces healthcare costs associated with CHF management. Remote monitoring devices, for instance, can track vital signs and detect early warning signs of deterioration, prompting appropriate medical responses and preventing severe complications.²³

Geographically, CHF prevalence aligns with regions experiencing high rates of hypertension, DM, and obesity, such as the Southern United States, particularly in Mississippi, Alabama, and Louisiana. Addressing CHF in these areas requires a multifaceted approach, combining public health initiatives with patient education and the deployment of advanced technology to bridge healthcare delivery gaps.²² Telehealth interventions have significantly improved CHF management and patient outcomes. The American Heart Association highlights the ability of telehealth to extend healthcare coverage to under-resourced areas, overcoming barriers such as physical disabilities, transportation challenges, and limited healthcare access.²⁴

Telehealth interventions have shown potential for reducing unplanned hospitalizations, decreasing hospital stays, and lowering mortality rates among patients with CHF.²⁴ For example, the Telemedical Interventional Management in Patients With Heart Failure (TIM-HF2) trial results demonstrated that remote patient monitoring led to significantly fewer median days lost due to unplanned cardiovascular hospitalizations and all-cause mortality.²⁴ These results emphasize telehealth’s role in proactive management, enabling timely adjustments to treatments and preventing complications.²⁴

Telehealth also facilitates patient education and coaching, as evidenced by the Baroreflex Activation Therapy in Patients With Heart Failure (BEAT-HF) trial, where remote monitoring was combined with nurse-led pre-discharge education and telephone-based coaching. While BEAT-HF showed variable effectiveness in reducing readmission rates, other studies, including TIM-HF2, have consistently reported benefits in reducing hospitalizations and improving patient satisfaction.²⁵ Telehealth also enhances communication between patients and healthcare providers, enabling the early identification of symptoms and timely interventions.²⁵ In addition, telehealth supports individualized patient care through tools such as remote monitoring devices, wearable technology, and teleconsultations.²³

Advanced devices like the CardioMEMS Heart Sensor system allow direct monitoring of pulmonary artery pressures, significantly reducing CHF-related hospitalizations by enabling real-time treatment adjustments. Wearable technology further enhances patient monitoring, tracking physical activity, sleep patterns, and physiological markers, such as atrial fibrillation, in CHF patients.²³

Teleconsultations provide virtual platforms for regular follow-up, medication adjustments, and adherence to guideline-directed medical therapy, improving patient convenience and reducing the need for in-person visits.²³ These interventions are particularly beneficial for elderly patients, who often face mobility challenges, and for individuals in remote or underserved areas. Digital technologies, including mobile phones and video conferencing platforms, enable routine healthcare interactions without requiring physical presence, ensuring continuity of care for patients with CHF.²⁴

Research underscores telehealth’s transformative potential in CHF management. The 2024 article, “Heart Failure Management through Telehealth: Expanding Care and Connecting Hearts,” published in the Journal of Clinical Medicine, highlights remote monitoring as a cornerstone of person-centered care. By continuously tracking vital signs and symptoms, telehealth enables early detection of clinical deterioration, allowing for timely interventions and reducing hospitalizations. The integration of telehealth technologies, ranging from simple sensors to advanced cardiovascular devices, enhances patient outcomes and supports proactive CHF management.²³

Hypertension

Hypertension requires ongoing management through medications such as angiotensin-converting enzyme inhibitors, beta-blockers, diuretics, and calcium channel blockers. If left uncontrolled, hypertension can lead to severe complications, including cardiovascular and cerebrovascular diseases, kidney damage, and a range of vision impairments. These complications contribute significantly to morbidity and mortality, especially in areas with poor access to healthcare and challenging socioeconomic conditions.²⁶

The Southern United States (e.g., Mississippi, Louisiana, and Alabama) report high rates of uncontrolled hypertension, compounded by socioeconomic disparities and limited healthcare infrastructure.²⁷ Telehealth has emerged as a transformative tool for hypertension management, offering innovative solutions to overcome traditional barriers to care.²⁸

One published review highlighted the benefits of telehealth interventions, including telemonitoring and teleconsultations. Telemonitoring, which involves the continuous remote monitoring of blood pressure, enables early detection of hypertension and facilitates timely adjustments to treatment plans, significantly improving clinical outcomes. Studies show that telemonitoring can achieve blood pressure control levels comparable to those of in-person care while reducing the need for frequent clinic visits.²⁸

Teleconsultations provide patients with access to medical advice and counseling remotely, increasing healthcare accessibility, particularly in rural and underserved areas. By minimizing travel requirements, teleconsultations improve adherence to regular follow-up and treatment plans, offering convenience and flexibility to both patients and providers. Additionally, mobile health (mHealth) applications have been integrated into hypertension management, offering features such as medication reminders, dietary and exercise guidance, and blood pressure logging. These tools enhance patient engagement and promote lifestyle changes critical for hypertension control.²⁸

The Telemonitoring and Self-Monitoring in Hypertension trial, conducted in the West Midlands, UK, evaluated the effectiveness of combining telemonitoring with self-monitoring practices among patients with elevated blood pressure. This study demonstrated that telemonitoring fosters greater patient engagement and empowerment by encouraging regular self-monitoring. It also facilitates timely communication between patients and healthcare providers, enabling rapid treatment adjustments and reducing the risk of hypertension-related complications.²⁹

One of the unique benefits of telemonitoring is its ability to provide real-time, accurate data through digital transmission, reducing errors associated with manual data recording. This feature supports structured hypertension management plans and improves clinical decision-making. While telemonitoring requires changes in healthcare workflows to integrate patient data management systems, its overall benefits in improving communication, engagement, and data quality outweigh the logistical challenges.²⁹

Telehealth interventions, such as mHealth tools, also improve medication adherence and patient involvement in health management. For example, Short Message Service text messaging enhances adherence to prescribed antihypertensive medications, resulting in significant reductions in systolic and diastolic blood pressure. Telehealth also facilitates team-based care, uniting physicians, nurses, and pharmacists to provide comprehensive hypertension management. This approach has been particularly effective in resource-limited settings, such as rural Western Kenya, where tablet-based decision-support systems enable healthcare providers to manage hypertension effectively.²⁹

Research further underscores the transformative potential of telehealth in the management of hypertension. Key advantages include remote monitoring of vital signs, patient education on lifestyle modifications, and increased adherence to treatment plans through frequent follow-ups and video consultations. Telehealth also addresses logistical barriers, such as transportation and time constraints, improving access to care for underserved populations. By integrating self-measured blood pressure monitoring into electronic health records, telehealth enhances data accuracy and supports evidence-based treatment decisions.³⁰

Although telehealth offers numerous benefits, its widespread implementation faces challenges, including the need for stable internet connections, access to appropriate technology, and integration into existing healthcare workflows. Despite these limitations, telehealth represents a promising avenue for improving hypertension management, reducing healthcare disparities, and promoting better health outcomes.³⁰

Chronic Obstructive Pulmonary Disease

COPD, a progressive lung condition, is characterized by persistent airflow limitation due to long-term exposure to irritants such as cigarette smoke or environmental pollutants. Complications associated with COPD include chronic bronchitis, emphysema, and increased susceptibility to other respiratory conditions and lung cancer.³¹ This disease imposes significant challenges on healthcare systems, particularly in rural and economically disadvantaged areas, such as Kentucky, West Virginia, and Mississippi in the United States, which have high smoking rates and limited healthcare infrastructure.³²

Vulnerable populations, including those who are financially insecure, elderly, and Native American communities, face heightened risks due to socioeconomic and health disparities.³³ Telehealth has emerged as a transformative solution for COPD management, addressing critical aspects of care such as diagnosis, treatment, monitoring, education, and prevention.³⁴

Studies conducted before the COVID-19 pandemic demonstrated that telehealth interventions, including asynchronous remote monitoring and virtual consultations, effectively reduced hospitalization risks for COPD patients compared to standard care. One trial revealed that automated daily check-ins and active monitoring systems significantly improved symptom management and reduced hospital admissions. During the COVID-19 pandemic, telehealth adoption accelerated, enabling continued care delivery despite restrictions on in-person consultations.³⁴

Telehealth facilitated video and telephone consultations, maintaining patient–provider communication while minimizing exposure risks. A survey conducted early in the pandemic found that most healthcare providers transitioned to telemedicine for the COPD management, with patients and providers reporting high satisfaction levels due to convenience and time savings.³⁴

Telehealth interventions for COPD include remote monitoring of vital signs, video appointments for self-management reviews, and tailored education programs. For instance, patients can receive guidance on inhaler techniques and self-management strategies during virtual consultations, improving adherence to treatment plans. Digital connectivity also enables the recruitment of rural residents into health-promoting activities, such as internet-based walking programs, increasing patient engagement and participation.³⁴

Educational initiatives leveraging telehealth platforms enhance COPD management. The University of Virginia developed low-bandwidth educational videos on topics such as smoking cessation and pulmonary rehabilitation, enabling patients in remote areas to access valuable resources. These interventions promote patient education and empower individuals to manage their condition effectively.³⁴ Legislative initiatives, such as the BREATHE Act, aim to expand telehealth reimbursement for respiratory therapists, further supporting COPD care.³⁵

One umbrella review synthesized evidence from seven systematic reviews, highlighting the benefits of telehealth for COPD management. Telehealth interventions, such as telemonitoring and telesupport, significantly reduced hospitalization rates, improved quality of life, and decreased mortality among COPD patients. Telemonitoring facilitates early detection of exacerbations, enabling timely interventions and reducing disease progression.³⁶

Integrated telemedicine approaches combining remote monitoring, treatment, and support have demonstrated compelling improvements in physical activity and patient engagement. Despite its advantages, barriers to telehealth adoption in COPD care remain, including limited technological capacity in rural areas and the need for in-person assessments for certain treatments, such as pulmonary rehabilitation. Addressing these challenges through investments in infrastructure and policy reforms is essential to maximizing telehealth’s potential in improving COPD management and patient outcomes.³⁶

Obesity

Obesity poses significant health risks, including type 2 diabetes, hypertension, cardiovascular diseases, and certain cancers. Additional complications include osteoarthritis, sleep apnea, and fatty liver disease, which further contribute to life-threatening conditions like cardiovascular and cerebrovascular diseases.³⁷ The epidemic of obesity disproportionately affects rural and economically disadvantaged areas, such as Mississippi, West Virginia, and Alabama, USA, where healthcare infrastructure is underdeveloped, and socioeconomic challenges prevail.³⁸ Vulnerable populations, including uninsured individuals, financially unstable groups, young adults, older adults, and Native American communities, face increased risks due to shared socioeconomic and health determinants.³⁹

Poor dietary habits and sedentary lifestyles exacerbate obesity-related metabolic syndrome and public health concerns.⁴⁰ Telehealth has demonstrated considerable benefits in obesity management, particularly during the COVID-19 pandemic, when in-person care was limited. For example, the Siempre telemedicine program launched in Colombia during the pandemic utilized real-time video consultations via Microsoft Teams to provide personalized care for obese patients.⁴¹ Participants experienced an average weight loss of 4.1 kg (9 lb) over 6 months, along with improved management of comorbidities such as DM and hypertension.⁴¹

Telehealth interventions facilitated continuous monitoring of metabolic parameters, including fasting blood glucose and lipid profiles, ensuring timely adjustments to treatment plans. Telehealth enhances accessibility by allowing patients to attend consultations from their homes, eliminating travel-related barriers. This is particularly beneficial for patients with disabilities or those in geographically remote areas. The flexibility of teleconsultations also increases the frequency and regularity of follow-ups, improving adherence to treatment plans and lifestyle modifications. Digital health tools integrated into telehealth platforms enable patients to track behaviors, receive reminders, and make healthier choices, thereby supporting long-term weight management.⁴¹

According to Florencia Halperin, MD, MMSc, telehealth bridges gaps in obesity care by connecting patients in underserved areas to obesity medicine specialists and multidisciplinary teams, including dietitians, exercise specialists, and mental health professionals. Telehealth reduces healthcare costs by minimizing travel expenses and time missed from work, while laws mandating insurance coverage for telehealth services further enhance its accessibility. The privacy and comfort provided by telehealth mitigate stigma and psychological barriers associated with traditional obesity care settings.⁴²

Frequent virtual appointments and personalized care delivery during the pandemic demonstrated high patient satisfaction and engagement, leading to better weight loss outcomes.⁴² Telehealth interventions in pediatric and adolescent obesity management focus on behavioral changes and lifestyle modifications. Platforms offering online nutritional support and exercise programs promote healthier lifestyles while addressing sedentary behaviors. Remote monitoring tools, such as glucometers and blood pressure cuffs, enable real-time data sharing with healthcare providers, facilitating timely interventions.⁴³

Tele-exercise and tele-nutrition programs further personalize obesity management, improving patient engagement and satisfaction. Despite its benefits, telehealth faces challenges, including the need for stable internet connectivity and access to appropriate technology. However, the cost-effectiveness, convenience, and improved access associated with telehealth outweigh these limitations, making it a promising approach for long-term obesity care. Studies show significant reductions in body mass index and caloric intake among telehealth participants, underscoring its potential to improve quality of life and reduce healthcare costs.⁴³

Cancer

Cancer is characterized by the uncontrolled growth and spread of abnormal cells in the body, leading to various forms, such as lung, breast, prostate, and colorectal cancers. Complications associated with cancer include anemia, thrombocytopenia, cachexia, and conditions like respiratory failure and systemic infections. The disease places a significant burden on public health systems due to the need for ongoing, intensive care, resulting in high morbidity and mortality rates. Rural and economically disadvantaged areas, including Kentucky, Mississippi, and Louisiana, USA, face greater challenges in managing cancer due to limited access to quality healthcare and socioeconomic hardships.⁴⁴

Vulnerable populations, such as financially unstable individuals, minority communities, young adults, and older adults, are disproportionately affected, experiencing higher rates of late-stage diagnoses and mental health issues like depression and anxiety. Telehealth has emerged as a transformative tool for cancer care, offering numerous benefits to patients, particularly during the COVID-19 pandemic. For instance, the Moffitt Cancer Center in Tampa, Florida, USA, reported significant financial and time savings from telehealth interventions, with patients saving an average of $147 to $186 per visit, 2.9 h of drive time, and 1.2 h of in-clinic time per visit. These savings alleviated financial burdens and enhanced patients’ quality of life by allowing them to allocate saved resources for other pressing needs.⁴⁴

Telehealth appointments offered flexibility, enabling patients to schedule consultations around their personal and work commitments, minimizing disruptions to daily life. Teleoncology, a subspecialty of telehealth, addresses the geographic mismatch between oncology services and patient populations, expanding access to care in rural and underserved areas. Real-time video consultations and service bundling, such as combining teleradiology, telepathology, and teleoncology, enhance clinical and cost efficiency while improving patient satisfaction. Teleoncology innovations also facilitate remote supervision during chemotherapy, follow-up care, symptom management, and palliative care using portable, home-based technologies. Mobile health applications support continuous monitoring of vital signs and patient engagement through ongoing text messaging. Telehealth extends access to cancer clinical trials by allowing eligibility assessments, consent, participation, and follow-ups to be conducted remotely, thereby including patients from non-urban areas.⁴⁵

Telepathology has revolutionized cancer care by enabling the remote viewing of microscopic images and improving diagnostic accuracy and efficiency. Future directions for telehealth in oncology include large-scale asynchronous telepathology initiatives and mobile applications for cancer prevention, treatment, and palliative care. Despite barriers such as technology costs, inconsistent reimbursement regulations, and data security risks, telehealth improves care coordination, early disease detection, and individualized treatment, ultimately enhancing the quality of life for cancer patients.⁴⁵

Cancer encompasses a diverse group of diseases, including lung, breast, prostate, and colorectal cancers, that significantly impact public health through high prevalence, mortality rates, and quality-of-life implications. Cancer complications, such as anemia, thrombocytopenia, and cachexia, often contribute to systemic infections and respiratory failure. The disease disproportionately affects rural and economically depressed regions, such as Kentucky, Mississippi, and Louisiana, USA, where healthcare access and socioeconomic conditions are limited. Vulnerable populations, including financially unstable individuals, minorities, and residents of rural areas, face heightened risks due to delayed diagnoses and limited treatment options. Telehealth has emerged as a transformative tool in cancer care, providing numerous benefits during the COVID-19 pandemic and beyond.⁴⁶

The Moffitt Cancer Center reported significant savings for patients using telehealth, including $147 to $186 per visit and reduced travel times by an average of 2.9 h per visit. These savings translate to improved quality of life for patients, enabling them to allocate resources toward other needs. Telehealth also facilitates flexible scheduling, allowing patients to integrate appointments into their daily lives without major disruptions. Teleoncology, a subspecialty of telehealth, addresses the geographic mismatch between oncology specialists and patient populations, expanding access to care for rural and underserved communities. Teleoncology services include video consultations, teleradiology, telepathology, and tele genetics, enhancing clinical efficiency and patient satisfaction. Remote supervision of chemotherapy, follow-up care, and mobile health applications for symptom management further streamline cancer care, reducing the need for frequent in-person visits.⁴⁷

Telehealth also extends access to clinical trials, which are often limited to urban populations. Virtual platforms facilitate eligibility assessments, consent processes, and participation, allowing broader patient involvement. Innovations like telepathology enable remote microscopic image analysis, ensuring accurate diagnoses and efficient evaluations. Despite challenges such as inconsistent regulations and data security concerns, telehealth enhances care coordination, early detection, and individualized treatment approaches, improving quality of life for cancer patients.⁴⁸

Discussion

Key Findings and Contributions

The digital health technologies offer enormous promise in management through telehealth interventions for patients with chronic diseases. The ensuing discussion brings to light findings related to DM, CHF, hypertension, and obesity, among other conditions (Table 2). It further acts as a source to comprehend how various multiple chronic conditions do or do not run in parallel—a major gap within the literature thus far.

Table 2. Summary of studies and outcomes.

Disease	Study	Digital Health Tools	Outcome	Implications	Key Gaps	Future Directions	Limitations
Diabetes Mellitus	Aleppo et al.10	Telemonitoring Comprehensive telehealth model	Improved HbA1c and self-management Enhanced adherence and patient satisfaction	Increased access for rural populations Effective integration into standard diabetes care	Limited real-world implementation studies on CGM effectiveness	AI-driven predictive analytics for glycemic control, digital decision-support tools for diabetes care	Lack of long-term cost-effectiveness data, potential user resistance to continuous monitoring
CHF	Tedeschi et al.24	Remote patient monitoring Telemonitoring	Reduced hospital readmissions by 25%. Reduced disparities in CHF outcomes	Early symptom detection reduces healthcare costs. Addresses inequities in ethnic populations	Variability in patient adherence, need for structured telehealth integration in cardiac care	Integration of machine learning for real-time risk prediction, development of patient engagement strategies for sustained adherence	Heterogeneity in study designs, differences in healthcare infrastructure affecting scalability
Hypertension	Grant et al.48 Idris et al.25	mHealth applications Telehealth within healthcare	Better BP control and patient engagement. Increased lifestyle modifications	Enhanced adherence to treatment plans Scalable solution for primary healthcare settings	Barriers in patient digital literacy, disparities in access to telehealth services	Development of adaptive mHealth tools with personalized feedback, expansion of mobile-based hypertension management	Varying compliance rates, lack of standardization in mHealth interventions
Obesity	Calcaterra et al.39 Ghosh et al.34	Virtual nutrition and exercise programs Telehealth for lifestyle modification	Sustained weight loss Reduced sedentary risks	Effective for pediatric obesity management Mitigates obesity-related comorbidities	Limited integration with primary care, long-term engagement challenges	AI-driven behavioral interventions, expansion of virtual group-based weight loss programs	High dropout rates in virtual obesity management programs, potential bias in self-reported data
Cancer	Sirintrapun et al.42 Shaffer et al.17	Telemedicine consultations Digital health platforms	Improved access to cancer care, reduced travel burden Enhanced patient satisfaction and adherence to treatment plans	Effective integration for follow-up care Reduces financial and logistical barriers	Limited telehealth reimbursement policies, lack of standardization in teleoncology services	Development of teleoncology guidelines, expansion of remote chemotherapy supervision	Data privacy concerns, lack of large-scale randomized controlled trials in teleoncology
Opioid Use Disorder	Zang et al.5 Monico et al.6	Naloxone distribution through digital platforms Telehealth-delivered behavioral therapies	Enhanced overdose prevention and patient engagement. Improved access to treatment.	Cost-effective solution for underserved populations. Increases scalability of interventions	Digital literacy challenges, regulatory concerns surrounding online medication distribution	AI-powered predictive analytics for relapse prevention, expansion of virtual peer-support groups	Limited longitudinal data on telehealth effectiveness in OUD management
COPD	Sculley et al.38 Koh et al.40	Telemonitoring Digital health interventions	Improved symptom management and reduced exacerbations Increased patient self-efficacy	Optimizes long-term care Reduces hospital admissions and associated costs.	Limited integration with primary pulmonary care, disparities in broadband access	Expansion of remote pulmonary rehabilitation programs, AI-based early warning systems	Variability in patient engagement, need for reimbursement model standardization
Stroke	Nayak-Rao et al.36	Remote monitoring for post-stroke care Telemedicine for rehabilitation	Improved recovery outcomes and early detection of complications Enhanced patient access to specialists	Reduces geographic barriers Supports timely interventions	Need for more research on long-term outcomes	Integration of wearable stroke monitoring devices, real-time rehabilitation support	Limited availability of specialized tele-stroke services
BP: blood pressure; HbA1c: hemoglobin A1c; CHF: congestive heart failure; OUD: opioid use disorder; CGM: continuous glucose monitoring.

Some studies go even further in showing how broad-based models of telehealth can facilitate better patient adherence and satisfaction by incorporating integrated digital tools.¹⁸ These studies both show the potential for telehealth to fill gaps in healthcare coverage within underserved communities, which has not been as widely discussed in earlier reviews.

Digital health interventions, such as CGM and AI-driven insulin management, improve glycemic control and reduce complications. The systematic review and meta-analysis, covering 11,000+ participants, confirm that CGM leads to significant reductions in HbA1c levels and fewer diabetes-related complications.⁴⁹ Additionally, AI-based decision-support systems optimize insulin dosing and patient education.

Telemonitoring has significantly averted hospital readmissions due to the timely identification of symptoms.⁴⁹ This stressed that digital interventions have the potential to reduce disparities in CHF outcomes among ethnicities. A significant finding of this review is that while telehealth is effective for CHF management, variability in patient adherence is still an issue and thus points to the need for behavioral interventions in addition to technology adoption.

Grant et al. reviewed mHealth interventions for hypertension, showing improved blood pressure control and greater patient engagement.⁴⁸ Similarly, Idris et al. also emphasized the scalability of telehealth interventions in the management of hypertension within a primary healthcare setting and demonstrated improved adherence to lifestyle modifications.²⁵ Despite these, digital literacy barriers remain a concern, especially in older and low-income populations, which further limits wide dissemination.

Calcaterra et al. demonstrated the use of telehealth in managing pediatric obesity, especially during the COVID-19 pandemic.³⁹ The virtual nutrition and exercise programs led to sustained weight loss and a healthier lifestyle. Ghosh et al. further emphasized how telehealth can reduce the risks for sedentary behavior among urban populations.³⁴ However, challenges such as high dropout rates in virtual obesity management programs raise the need for long-term strategies to engage people.

Gaps in the Existing Literature

This review extends prior work by providing a wider comparative framework across major chronic conditions and not through individual disease-specific interventions. Many previous reviews, such as those by Pong et al.¹ and Taylor et al.,² provided a broad overview of digital health experiences within specific diseases but without synthesis across conditions. This comprehensive review identifies key trends in telehealth, such as the role of telehealth in the reduction of hospitalizations, improving medication adherence, and expanding healthcare access, while also discussing systemic barriers to its implementation.

A critical limitation of the previous literature is the general lack of long-term data on digital health interventions. Although there are numerous reports of short-term benefits, such as improved disease management and cost savings, few studies have explored the multiple-year sustainability of such interventions. Future studies should give priority to longitudinal analyses to conclusively determine the durability of telehealth benefits.

Challenges and Future Considerations

Digital health technologies bundle advantages, but their implementation comes with challenges. Data privacy, interoperability, and regulatory concerns continue to be major issues to be resolved to make telehealth widely used. Moreover, unequal rates of digital literacy and access to broadband widen the gap in accessing these technologies, especially in rural and poor communities. Policymakers should prioritize the development of telehealth infrastructure and digital literacy initiatives to bridge these gaps.

Therefore, the long-term cost-effectiveness of digital health interventions is still an open question. Future research on multi-year studies regarding the financial sustainability of telehealth programs should inform policy decisions and investments in healthcare. The integration of AI in the management of chronic diseases holds great promise for personalized medicine, improved adherence, and predictive analytics. More studies are called for on AI-driven decision support systems applied to telehealth applications. Table 3 lists challenges in critical areas of telehealth.

Table 3. Future challenges for researchers in critical areas of telehealth.

Challenges	Need
Long-term cost-effectiveness	Longitudinal studies evaluating the financial sustainability of digital health interventions.
AI-driven personalized care	Machine learning algorithms that optimize treatment recommendations based on patient data.
Strategies for improving patient adherence	Explore the psychological and behavioral factors influencing long-term engagement with telehealth programs.
Ethical and legal frameworks	Ongoing assessment of ethical considerations, liability concerns, and regulatory updates in the evolving landscape of AI in digital health.
Health equity and accessibility	Closing digital literacy gaps and expanding telehealth access to marginalized communities.
AI: artificial intelligence.

Policy and Regulatory Considerations

While these solutions enjoy many advantages, there are ongoing challenges in policy, reimbursement models, and regulatory frameworks. The COVID-19 pandemic saw an increase in telehealth, demonstrating the flexibility of reimbursement policies but also creating permanent regulatory frameworks that protect fair access beyond that pandemic era. Standardized guidelines on telehealth in general, and regarding OUD treatment and medical oncology specifically, are lacking.

In addition, issues related to data privacy, cybersecurity, and consent from patients remain urgent. However, with increasing dependence on digital platforms, more stringent regulations concerning data protection are called for in sustaining the trust of the patient in telehealth services.

The successful integration of digital health technologies into standard care requires clear policy frameworks, regulatory alignment, and reimbursement structures. Key policy challenges facing policymakers and researchers are listed in Table 4.

Table 4. Key policy challenges facing policymakers and researchers for the successful integration of digital health technologies into standard care.

Challenges	Need	Action
Disparities in telehealth reimbursement	Despite the widespread adoption of telehealth, reimbursement policies remain inconsistent across healthcare systems.	Policymakers should establish uniform reimbursement models to encourage long-term adoption.
Data privacy and security	Digital health interventions involve sensitive patient data, making compliance with HIPAA and GDPR.	Future regulatory frameworks should standardize cybersecurity protocols across telehealth platforms.
Licensure and cross-state regulations	Many telehealth providers face challenges related to interstate licensure laws, restricting healthcare access across regions.	Policymakers should explore national licensure compacts to facilitate seamless telehealth services.
Equitable access:	Socioeconomic disparities continue to limit telehealth adoption in rural and underserved communities.	Investment in broadband infrastructure and digital literacy programs is critical for reducing access gaps.
AI and regulatory oversight:	There is an increasing role of AI in clinical decision-making.	Regulatory bodies must develop AI governance frameworks that ensure ethical deployment and minimize bias in healthcare algorithms.
AI: artificial intelligence; GDPR: General Data Protection; HIPAA: Health Insurance Portability and Accountability Act.

Digital Health Disparities and Implementation Barriers

While telehealth increases access to healthcare, socioeconomic disparities, and gaps in digital literacy, technological barriers continue to hinder its complete realization. Most of the rural communities, lower-income populations, and elderly patients have difficulties in accessing and utilizing digital health tools. Therefore, community-based digital literacy programs, among other initiatives and investments in infrastructure by policymakers and health systems, will ensure that telehealth diffuses equitably.

Future Research Directions

Table 5 lists challenges and action items for future research.

Table 5. Challenges and action items for future research.

Need	Rationale
Longitudinal studies on cost-effectiveness	Future research should be directed at multi-year studies of the financial sustainability and long-term impact of telehealth interventions.
AI and predictive analytics integration	There is growing interest in using machine learning models to enhance the effectiveness of telehealth by predicting patient deterioration and optimizing treatment plans.
Behavioral interventions for digital health adherence	Gamification, personalized health coaching, and AI-driven patient engagement are examples of the strategies to explore in developing long-term adherence to digital health programs.
Standardization of telehealth policies	Future research should address the development of universal telehealth guidelines to guarantee equitable access and quality across the health systems.
AI: artificial intelligence.

Conclusion

This review contributes a unique comparative perspective through a systematic synthesis of the findings from multiple chronic conditions, adding value to the existing literature. Telehealth and connected digital health interventions have established significant effectiveness for a wide array of chronic conditions, including OUD, DM, CHF, hypertension, COPD, obesity, and cancer. Unlike prior disease-specific reviews, this study highlights cross-cutting challenges and opportunities that apply across multiple chronic diseases.

Telehealth has resulted in improved medication adherence, lower recidivism rates, and generally improved outcomes in OUD. However, policy deliberations should be constant if the regulatory concerns regarding opioid addiction treatment remotely are to be overcome. Virtual consultation services have been crucial in maintaining patients and facilitating timely interventions through remote monitoring mechanisms that reduce the complications of opioid misuse.

With CGM and insulin pumps, there has been a quantum jump in managing DM. Newer digital health technologies are taking glycemic control further and decreasing complications. The development of programs such as the IHS-JVN Program created access to needed eye care for diabetic patients from the underserved sections of the population and highlighted how telehealth could help reduce geospatial and financial barriers to specialist care.

CHF management has benefited from real-time monitoring and consultations remotely, thus reducing admissions and mortality. However, consistency from patients is still a major challenge, for which behavioral models are necessary for digital interventions. Similarly, regarding hypertension, early detection by telemonitoring has enabled improvement in the continuity of blood pressure management, reduction of hospitalization, and facilitation of real-time treatment adjustment. Therefore, future research should be channeled toward integrating AI-powered predictive analytics to enhance early detection and intervention in hypertension management.

Telehealth has been instrumental in COPD management, especially during the COVID-19 pandemic, through the provision of continuous care, remote patient education, and video consultations, reducing in-person visits, thus ensuring timely interventions. Thus, telehealth enables participation in health-promoting activities and improves the quality of life of patients with COPD. Despite these benefits, disparities in broadband access and digital literacy remain significant barriers to equitable implementation.

For the management of obesity, telehealth has opened avenues for individualized lifestyle modification programs, nutritional counseling on virtual platforms, and even metabolic monitoring from a distance. The “Siempre” telemedicine initiative, an alternative for outpatient care during the COVID-19 pandemic, showed promising results in weight management and metabolic control, showcasing the potential of telehealth in mitigating the obesity epidemic. However, dropout rates in virtual weight management programs help identify strategies to enhance patient retention and engagement.

In oncology, telehealth has played a game-changing role. Teleoncology has expanded cancer care by making remote follow-up consultations possible, supervision of chemotherapy, and participation in clinical trials. However, reimbursement limitations and regulatory barriers continue to be obstacles to the wide diffusion of the teleoncology services.

Final Remarks

This review has underlined the transformative potential of digital health technologies in the management of chronic diseases while recognizing the challenges that have to be overcome for its wider diffusion. Addressing policy barriers, enhancing digital health literacy, and investing in AI-driven solutions will optimize telehealth for providing equitable and sustainable healthcare to diverse populations. Future research and policy efforts should be channeled to refine the models of telehealth, expansion of access, and long-term sustainability of digital health interventions in chronic disease management.

Contributors

Mr. Asif contributed to conceptualization, methodology, data collection, writing the original draft, review and editing, and project administration. Dr. Gaur supervised the development of the manuscript and contributed to editing, conceptual guidance, and feedback on manuscript revisions.

Data Availability Statement (DAS), Data Sharing, Reproducibility, and Data Repositories

The data that support the findings of this study are openly available in publicly accessible repositories. The authors confirm that no additional datasets were generated or analyzed during the current study, as it is a literature review.

Application of AI-Generated Text or Related Technology

No AI-generated text or related technologies were used in the drafting, editing, or analysis of this manuscript.

Acknowledgments

The authors thank Dr. Pramod Gaur for his guidance during the development of this manuscript and for providing valuable feedback and resources throughout the process.

References

1. Pong C, Tseng RMWW, Tham YC, Lum E. Current implementation of digital health in chronic disease management: scoping review. J Med Internet Res. 2024;26:e53576. https://doi.org/10.2196/53576
2. Taylor ML, Thomas EE, Vitangcol K, Marx W, Campbell KL, Caffery LJ, et al. Digital health experiences reported in chronic disease management: an umbrella review of qualitative studies. J Telemed Telecare. 2022;28(10):705–17. https://doi.org/10.1177/1357633X221119620
3. Sapna F, Raveena F, Chandio M, Bai K, Sayyar M, Varrassi G, et al. Advancements in heart failure management: a comprehensive narrative review of emerging therapies. Cureus. 2023 [cited 2025 Jan 31]. Available from: https://www.cureus.com/articles/195799-advancements-in-heart-failure-management-a-comprehensive-narrative-review-of-emerging-therapies
4. Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain—United States, 2022. MMWR Recomm Rep. 2022;71(3):1–95. https://doi.org/10.15585/mmwr.rr7103a1
5. Zang X, Skinner A, Krieger MS, Behrends CN, Park JN, Green TC, et al. Evaluation of strategies to enhance community-based naloxone distribution supported by an opioid settlement. JAMA Netw Open. 2024;7(5):e2413861. https://doi.org/10.1001/jamanetworkopen.2024.13861
6. Monico LB, Eastlick M, Michero D, Pielsticker P, Glasner S. Feasibility and acceptability of a novel digital therapeutic combining behavioral and pharmacological treatment for opioid use disorder. Digit Health. 2024;10:20552076241258400. https://doi.org/10.1177/20552076241258400
7. Mongelli F, Georgakopoulos P, Pato MT. Challenges and opportunities to meet the mental health needs of underserved and disenfranchised populations in the United States. Focus Am Psychiatr Publ. 2020;18(1):16–24. https://doi.org/10.1176/appi.focus.20190028
8. Goins RT, Pilkerton CS. Comorbidity among Older American Indians: the native elder care study. J Cross-Cult Gerontol. 2010;25(4):343–54. https://doi.org/10.1007/s10823-010-9119-5
9. Magid DJ, Shetterly SM, Margolis KL. Comparative effectiveness of angiotensin-converting enzyme inhibitors versus beta-blockers as second-line therapy for hypertension. Circ Cardiovasc Qual Outcomes. 2010;3(5):453–8. https://doi.org/10.1161/CIRCOUTCOMES.110.940874
10. Aleppo G, Gal RL, Raghinaru D, Kruger D, Beck RW, Bergenstal RM, et al. Comprehensive telehealth model to support diabetes self-management. JAMA Netw Open. 2023;6(10):e2336876. https://doi.org/10.1001/jamanetworkopen.2023.36876
11. Clinic M. COPD—Symptoms and causes. Mayo Clin. 2020 [cited 2024 Dec 29]. Available from: https://www.mayoclinic.org/diseases-conditions/copd/symptoms-causes/syc-20353679 [cited 29 December 2024].
12. Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, et al. Cost-effectiveness of treatments for opioid use disorder. JAMA Psychiatry. 2021;78(7):767. https://doi.org/10.1001/jamapsychiatry.2021.0247
13. Hamid H, Abid Z, Amir A, Rehman TU, Akram W, Mehboob T. Current burden on healthcare systems in low- and middle-income countries: recommendations for emergency care of COVID-19. Drugs Ther Perspect. 2020;36(10):466–8. https://doi.org/10.1007/s40267-020-00766-2
14. Kropp M, Golubnitschaja O, Mazurakova A, Koklesova L, Sargheini N, Vo TTKS, et al. Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation. EPMA J. 2023;14(1):21–42. https://doi.org/10.1007/s13167-023-00314-8
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(Suppl 1):S62–S69. https://doi.org/10.2337/dc10-S062
16. Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, et al. Differences in the incidence of congestive heart failure by ethnicity: the multi-ethnic study of atherosclerosis. Arch Intern Med. 2008;168(19):2138. https://doi.org/10.1001/archinte.168.19.2138
17. Shaffer KM, Turner KL, Siwik C, Gonzalez BD, Upasani R, Glazer JV, et al. Digital health and telehealth in cancer care: a scoping review of reviews. Lancet Digit Health. 2023;5(5):e316–27. https://doi.org/10.1016/S2589-7500(23)00049-3
18. Moschonis G, Siopis G, Jung J, Eweka E, Willems R, Kwasnicka D, et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Lancet Digit Health. 2023;5(3):e125–43.
19. Alzahrani S, Al Doghaither H, Al‑Ghafari A. General insight into cancer: an overview of colorectal cancer (Review). Mol Clin Oncol. 2021;15(6):271. https://doi.org/10.3892/mco.2021.2433
20. Liu L, Yin X, Chen M, Jia H, Eisen HJ, Hofman A. Geographic variation in heart failure mortality and its association with hypertension, diabetes, and behavioral-related risk factors in 1,723 counties of the United States. Front Public Health. 2018;6:132. https://doi.org/10.3389/fpubh.2018.00132
21. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660
22. Tradeoffs. Healing at home: pandemic lessons and the future of home care [Virtual event. Tradeoffs. 2023 [cited 2024 Dec 29]. Available from: https://tradeoffs.org/healing-at-home-event/HOME.
23. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e621. https://doi.org/10.1161/CIR.0000000000001123
24. Tedeschi A, Palazzini M, Trimarchi G, Conti N, Di Spigno F, Gentile P, et al. Heart failure management through telehealth: expanding care and connecting hearts. J Clin Med. 2024;13(9):2592. https://doi.org/10.3390/jcm13092592
25. Idris H, Nugraheni WP, Rachmawati T, Kusnali A, Yulianti A, Purwatiningsih Y, et al. How is telehealth currently being utilized to help in hypertension management within primary healthcare settings? A scoping review. Int J Environ Res Public Health. 2024;21(1):90. https://doi.org/10.3390/ijerph21010090
26. Service IH. IHS-Joslin Vision Network Teleophthalmology Program. U.S. Department of Health and Human Services [cited 2024 Dec 29]. Available from: https://www.ihs.gov/teleophthalmology/
27. Choe K, Zinn E, Lu K, Hoang D, Yang LH. Impact of COVID-19 pandemic on chronic pain and opioid use in marginalized populations: a scoping review. Front Public Health. 2023;11:1046683. https://doi.org/10.3389/fpubh.2023.1046683
28. Hub RHI. Increasing COPD care with telehealth. Rural Chronic Obstr Pulm Dis Toolkit. 2019 [cited 2024 Dec 29]. Available from: https://www.ruralhealthinfo.org/toolkits/copd/4/telehealth
29. Henry TA. New rules enable telemedicine treatment for opioid-use disorder. American Medical Association; 2024 [cited 2024 Dec 29]. Available from: https://www.ama-assn.org/delivering-care/overdose-epidemic/new-rules-enable-telemedicine-treatment-opioid-use-disorder
30. Dasgupta N, Beletsky L, Ciccarone D. Opioid crisis: no easy fix to its social and economic determinants. Am J Public Health. 2018;108(2):182–6. https://doi.org/10.2105/AJPH.2017.304187
31. Ahuja R, Ayala C, Tong X, Wall HK, Fang J. Public awareness of health-related risks from uncontrolled hypertension. Prev Chronic Dis. 2018;15:170362. https://doi.org/10.5888/pcd15.170362
32. Wu Y, Ding Y, Tanaka Y, Zhang W. Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. Int J Med Sci. 2014;11(11):1185–200. https://doi.org/10.7150/ijms.10001
33. Burkes RM, Gassett AJ, Ceppe AS, Anderson W, O’Neal WK, Woodruff PG, et al. Rural residence and chronic obstructive pulmonary disease exacerbations. Analysis of the SPIROMICS Cohort. Ann Am Thorac Soc. 2018;15(7):808–16.
34. Ghosh S, Paul M, Mondal KK, Bhattacharjee S, Bhattacharjee P. Sedentary lifestyle with increased risk of obesity in urban adult academic professionals: an epidemiological study in West Bengal, India. Sci Rep. 2023;13(1):4895. https://doi.org/10.1038/s41598-023-31977-y
35. Service IH. Special diabetes program for Indians (SDPI) basics. U.S. Department of Health and Human Services. Available from: https://www.ihs.gov/sdpi/sdpi-community-directed/sdpi-basics/
36. Nayak-Rao S, Shenoy M. Stroke in patients with chronic kidney disease…: how do we approach and manage it? Indian J Nephrol. 2017;27(3):167. https://doi.org/10.4103/0971-4065.202405
37. Winstead E. Telehealth can save people with cancer time, travel, and money. Natl Cancer Inst. 2023 [cited 2024 Dec 29]. Available from: https://www.cancer.gov/news-events/cancer-currents-blog/2023/telehealth-cancer-care-saves-time-money
38. Sculley JA, Musick H, Krishnan JA. Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic. Curr Opin Pulm Med. 2022;28(2):93–8. https://doi.org/10.1097/MCP.0000000000000851
39. Calcaterra V, Verduci E, Vandoni M, Rossi V, Di Profio E, Carnevale Pellino V, et al. Telehealth: a useful tool for the management of nutrition and exercise programs in pediatric obesity in the COVID-19 era. Nutrients. 2021;13(11):3689. https://doi.org/10.3390/nu13113689
40. Koh JH, Chong LCY, Koh GCH, Tyagi S. Telemedical interventions for chronic obstructive pulmonary disease management: umbrella review. J Med Internet Res. 2023;25:e33185. https://doi.org/10.2196/33185
41. Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: capabilities, features, barriers, and applications. Sens Int. 2021;2:100117. https://doi.org/10.1016/j.sintl.2021.100117
42. Sirintrapun SJ, Lopez AM. Telemedicine in cancer care. Am Soc Clin Oncol Educ Book. 2018;(38):540–5. https://doi.org/10.1200/EDBK_200141
43. Elder AJ, Alazawi H, Shafaq F, Ayyad A, Hazin R. Teleoncology: novel approaches for improving cancer care in North America. Cureus. 2023 [cited 2025 Jan 31]. Available from: https://www.cureus.com/articles/156603-teleoncology-novel-approaches-for-improving-cancer-care-in-north-america
44. Dorn F, Lange B, Braml M, Gstrein D, Nyirenda JLZ, Vanella P, et al. The challenge of estimating the direct and indirect effects of COVID-19 interventions – toward an integrated economic and epidemiological approach. Econ Hum Biol. 2023;49:101198. https://doi.org/10.1016/j.ehb.2022.101198
45. Obesity Action Coalition. The future of telehealth in obesity care. Obesity Action Coalition. Available from: https://www.obesityaction.org/resources/the-future-of-telehealth-in-obesity-care
46. Miller CE, Vasan RS. The southern rural health and mortality penalty: a review of regional health inequities in the United States. Soc Sci Med. 2021;268:113443. https://doi.org/10.1016/j.socscimed.2020.113443
47. Agarwal S, Simmonds I, Myers AK. The use of diabetes technology to address inequity in health outcomes: limitations and opportunities. Curr Diab Rep. 2022;22(7):275–81. https://doi.org/10.1007/s11892-022-01470-3
48. Grant S, Hodgkinson J, Schwartz C, Bradburn P, Franssen M, Hobbs FR, et al. Using mHealth for the management of hypertension in UK primary care: an embedded qualitative study of the TASMINH4 randomised controlled trial. Br J Gen Pract. 2019;69(686):e612–20. https://doi.org/10.3399/bjgp19X704585
49. Ciemins E, Coon P, Peck R, Holloway B, Min SJ. Using telehealth to provide diabetes care to patients in rural Montana: findings from the promoting realistic individual self-management program. Telemed E-Health. 2011;17(8):596–602. https://doi.org/10.1089/tmj.2011.0028

Copyright Ownership: This is an open-access article distributed in accordance with the Creative Commons Attribution Non-Commercial (CC BY-NC 4.0) license, which permits others to distribute, adapt, enhance this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0.